Cough: An unmet clinical need

British Journal of Pharmacology

Volumn 163, Issue 1, 2011, Pages 116-124

  Dicpinigaitis, Peter V ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

ACE inhibitors; anti tussive; asthma; bronchitis; common cold; cough; gastro oesophageal reflux disease (GERD); rhinosinusitis

Indexed keywords

ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BACLOFEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CISAPRIDE; CLOFEDANOL; CODEINE; CORTICOSTEROID DERIVATIVE; DECONGESTIVE AGENT; DEXBROMPHENIRAMINE; DEXTROMETHORPHAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DOMPERIDONE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE; NARCOTIC AGENT; PROTON PUMP INHIBITOR; TIOTROPIUM BROMIDE;

ACUTE COUGH; BEDTIME DOSAGE; CHRONIC COUGH; COMMON COLD; CONFUSION; COUGH VARIANT ASTHMA; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIFESTYLE MODIFICATION; MORNING DOSAGE; NON ASTHMATIC EOSINOPHILIC BRONCHITIS; NONHUMAN; OCCUPATIONAL EXPOSURE; PATIENT CARE; PERTUSSIS; POSTNASAL DRIP SYNDROME; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SEDATION; SIDE EFFECT; SUBACUTE COUGH; SUDDEN DEATH; TARDIVE DYSKINESIA; UNEXPLAINED COUGH; UPPER AIRWAY COUGH SYNDROME;

ANIMALS; ANTITUSSIVE AGENTS; CLINICAL TRIALS AS TOPIC; COUGH; DRUG DISCOVERY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS;

EID: 79953693585     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01198.x     Document Type: Review

References (84)

1. Adcock JJ, (2009). TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm Pharmacol Ther 22: 65-70.
2. Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A, (2007). Combined ph-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion 76: 223-228. (Pubitemid 351351678)
3. Bangalore S, Kumar S, Messerli FH, (2010). Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med 123: 1016-1030.
4. Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, et al,. (2005). Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 35: 598-601. (Pubitemid 40769283)
5. Berthet S, Charpiat B, Mabrut JY, (2010). Erythromycin as a prokinetic agent: risk factors. J Visc Surg 147: e13-e18.
6. Bickerman HA, German E, Cohen BM, Itkin SE, (1957). The cough response of healthy human subjects stimulated by citric acid aerosol. Am J Med Sci 234: 191-205.
7. Birring SS, Brightling CE, Symon FA, Barlow SG, Wardlaw AJ, Pavord ID, (2003). Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 58: 1066-1070. (Pubitemid 37542113)
8. Birring SS, Murphy AC, Scullion JE, Brightling CE, Browning M, Pavord ID, (2004). Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study. Respir Med 98: 242-246. (Pubitemid 38262658)
9. Bolser DC, (2006). Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 238S-249S. (Pubitemid 43265228)
10. Bolser DC, Aziz SM, DeGennaro FC, Kreutner W, Egan RW, Siegel MI, et al,. (1993). Antitussive effects of GABA-B agonists in the cat and guinea-pig. Br J Pharmacol 110: 491-495. (Pubitemid 23257824)
11. Braman SS, (2006). Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 138S-146S. (Pubitemid 43265215)
12. Brightling CE, (2010). Cough due to asthma and nonasthmatic eosinophilic bronchitis. Lung 188 (Suppl. 1): S13-S17.
13. Brooks SM, (2010). Occupational, environmental, and irritant-induced cough. Otolaryngol Clin North Am 43: 85-96.
14. Chang AB, Lasserson TJ, Kiljander TO, Connor FL, Gaffney JT, Garske LA, (2006). Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. BMJ 332: 11-17.
15. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA, (2008). National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Report 3: 1-39.
16. Cornia PB, Hersh AL, Lipsky BA, Newman TB, Gonzales R, (2010). Does this coughing adolescent or adult patient have pertussis? JAMA 304: 890-896.
17. Dicpinigaitis PV, (2006a). Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 75S-79S. (Pubitemid 43265208)
18. Dicpinigaitis PV, (2006b). Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 169S-173S. (Pubitemid 43265218)
19. Dicpinigaitis PV, Dobkin JB, (1997). Antitussive effect of the GABA-agonist baclofen. Chest 111: 996-999. (Pubitemid 27171472)
20. Dicpinigaitis PV, Dobkin JB, Reichel J, (2002). Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma 39: 291-297. (Pubitemid 34671102)
21. Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A, (2008). Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 186: 369-374.
22. Dicpinigaitis PV, Colice GL, Goolsby MJ, Rogg GI, Spector SL, Winther B, (2009). Acute cough: a diagnostic and therapeutic challenge. Cough 5: 11.
23. Eccles R, (2010). Importance of placebo effect in cough clinical trials. Lung 188 (Suppl. 1): S53-S61.
24. Eccles R, Morris S, Jawad M, (1992). Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 17: 175-180.
25. Eddy NB, Friebel H, Hahn K-J HH, (1969). Codeine and its alternates for pain and cough relief. Bull World Health Organ 40: 639-719.
26. FDA (1987). Cold, cough, allergy, bronchodilator and antiasthmatic drug products for over-the-counter human use; final monograph for OTC antitussive drug products. U.S. Department of Health and Human Services. Fed Regist 52: 30042-30057.
27. FDA (1994). Cold, cough, allergy, bronchodilator and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. U.S. Department of Health and Human Services. Fed Regist 59: 29172-29174.
28. Freestone C, Eccles R, (1997). Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 49: 1045-1049. (Pubitemid 27478402)
29. Gibson PG, Vertigan AE, (2009). Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther 22: 159-162.
30. Grattan TJ, Marshall AE, Higgins KS, Morice AH, (1995). The effect of inhaled and oral dextromethorphan on citric acid induced cough in man. Br J Clin Pharmacol 39: 261-263.
31. Greene SM, Simpson CB, (2010). Evidence for sensory neuropathy and pharmacologic management. Otolaryngol Clin North Am 43: 67-72.
32. Groneberg DA, Nowak D, Wussow A, Fischer A, (2006). Chronic cough due to occupational factors. J Occup Med Toxicol 1: 3.
33. Hewitt M, Canning BJ, (2010). Coughing precipitated by Bordetella pertussis infection. Lung 188 (Suppl. 1): S73-S79.
34. Iqbal M, Batch AJ, Moorthy K, Cooper BT, Spychal RT, (2009). Outcome of surgical fundoplication for extra-oesophageal symptoms of reflux. Surg Endosc 23: 557-561.
35. Irwin RS, (2006). Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 80S-94S. (Pubitemid 43265209)
36. Irwin RS, Curley FJ, French CL, (1990). Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outline of specific therapy. Am Rev Respir Dis 141: 640-647. (Pubitemid 20109152)
37. Irwin RS, Zawacki JK, Wilson MM, French CT, Callery MP, (2002). Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 121: 1132-1140. (Pubitemid 34280433)
38. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al,. (2006). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 1S-23S. (Pubitemid 43265198)
39. Joad JP, Sekizawa S, Chen CY, Bonham AC, (2007). Air pollutants and cough. Pulm Pharmacol Ther 20: 347-354. (Pubitemid 46518196)
40. Johannes CB, Varas-Lorenzo C, McQuay LJ, Midkiff KD, Fife D, (2010). Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf 19: 881-888.
41. Kahrilas PJ, (2010). Chronic cough and gastroesophageal reflux disease: new twists to the riddle (ed). Gastroenterology 139: 716-718.
42. Kardos P, Berck H, Fuchs K-H, Gillissen A, Klimek L, Morr H, et al,. (2010). Guidelines of the German Respiratory Society for diagnosis and treatment of adults suffering from acute or chronic cough. Pneumologie 64: 336-373.
43. Karttunen P, Tukiainen H, Silvasti M, Kolonen S, (1987). Antitussive effect of dextromethorphan and dextromethorphan-salbutamol combination in healthy volunteers with artificially induced cough. Respiration 52: 49-53. (Pubitemid 17096223)
44. Kaufman JA, Houghland JE, Quiroga E, Cahill M, Pellegrini CA, Oelschlager BK, (2006). Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc 20: 1824-1830. (Pubitemid 44852176)
45. Kita T, Fujimura M, Ogawa H, Nakatsumi Y, Nomura S, Ishiura Y, et al,. (2010). Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough. Allergol Int 59: 185-192.
46. Kohno S, Ishida T, Uchida Y, Kishimoto H, Sasaki H, Shioya T, et al,. (2006). The Japanese Respiratory Society guidelines for management of cough. Respirology 11 (Suppl. 4): S135-S186.
47. Kotzer CJ, Hay DWP, Dondio G, Giardina G, Petrillo P, Underwood DC, (2000). The antitussive activity of Î-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther 292: 803-809. (Pubitemid 30067447)
48. Krouse JH, Altman KW, (2010). Rhinogenic laryngitis, cough, and the unified airway. Otolaryngol Clin North Am 43: 111-121.
49. Kuo P, Holloway RH, (2010). Beyond acid suppression: new pharmacologic approaches for treatment of GERD. Curr Gastroenterol Rep 12: 175-180.
50. Lacy BE, Weiser K, Chertoff J, Fass R, Pandolfino JE, Richter JE, et al,. (2010). The diagnosis of gastroesophageal reflux disease. Am J Med 123: 583-592.
51. Layton D, Key C, Shakir SA, (2003). Prolongation of the QT interval and cardiac arrythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future. Pharmacoepidemiol Drug Saf 12: 31-40. (Pubitemid 36192947)
52. Lee BE, Kim GH, Ryu DY, Kim DU, Cheong GH, Lee DG, et al,. (2010). Combined dual channel impedance pH-metry in patients with suspected laryngopharyngeal reflux. J Neurogastroenterol Motil 16: 157-165.
53. Lim KG, (2010). Nitric oxide measurement in chronic cough. Lung 188 (Suppl. 1): S19-S22.
54. McGarvey LP, (2008). Does idiopathic cough exist? Lung 186 (Suppl. 1): S78-S81.
55. McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, et al,. (1998). Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 53: 738-743. (Pubitemid 28408713)
56. McGarvey LP, Forsythe P, Heaney LG, MacMahon J, Ennis M, (1999). Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur Respir J 13: 59-65. (Pubitemid 29079220)
57. McGlashan JA, Johnstone LM, Sykes J, Strugala V, Dettmar PW, (2009). The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 266: 243-251.
58. McLeod RL, Tulshian DB, Bolser DC, Varty GB, Baptista M, Fernandez X, et al,. (2010). Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[bis(2-chlorophenyl)methyl]-3-(2-pyrimidinyl)-8- azabicyclo[3,2,1]octan-3-ol) in preclinical models. Eur J Pharmacol 630: 112-120.
59. Merati AL, (2010). Reflux and cough. Otolaryngol Clin North Am 43: 97-110.
60. Morice AH, (2010). The Cough Hypersensitivity Syndrome: a novel paradigm for understanding cough. Lung 188 (Suppl. 1): S87-S90.
61. Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, et al,. (2004). The diagnosis and management of chronic cough. Eur Respir J 24: 481-492. (Pubitemid 39232274)
62. Morice AH, McGarvey L, Pavord I, British Thoracic Society Cough Guideline Group (2006). Recommendations for the management of cough in adults. Thorax 61 (Suppl. 1): i1-24. (Pubitemid 44369412)
63. Packman EW, Ciccone PE, Wilson J, Masurat T, (1991). Antitussive effects of diphenhydramine on the citric acid aerosol-induced cough response in humans. Int J Clin Pharmacol Ther Toxicol 29: 218-222.
64. Patterson N, Mainie I, Rafferty G, McGarvey L, Heaney L, Tutuian R, et al,. (2009). Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol 43: 414-419.
65. Pauwels A, Blondeau K, Dupont L, Sifrim D, (2009). Cough and gastroesophageal reflux: from the gastroenterologist end. Pulm Pharmacol Ther 22: 135-138.
66. Pavord ID, Chung KF, (2008). Chronic cough 2: management of chronic cough. Lancet 371: 1375-1384.
67. Poe RH, Kallay MC, (2003). Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123: 679-684. (Pubitemid 36315477)
68. Pratter MR, (2006a). Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 63S-71S. (Pubitemid 43265206)
69. Pratter MR, (2006b). Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl. 1): 220S-221S. (Pubitemid 43265225)
70. Pratter MR, Bartter T, Akers S, DuBois J, (1993). An algorithmic approach to chronic cough. Ann Intern Med 119: 977-983. (Pubitemid 23334653)
71. Proprietary Association of Great Britain (2005). IRI 2005 OTC market size statistics. Available at:.
72. Ramsay J, Wright C, Thompson R, Hull D, Morice AH, (2008). Assessment of antitussive efficacy of dextromethorphan in smoking related cough:objective vs. subjective measures. Br J Clin Pharmacol 65: 737-741. (Pubitemid 351535094)
73. Ranson ME, Danielson A, Maxwell JG, Harris JA, (2007). Prospective study of laparoscopic Nissen fundoplication in a community hospital and its effect on typical, atypical, and nonspecific gastrointestinal symptoms. JSLS 11: 66-71.
74. Rao AS, Camilleri M, (2010). Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther 31: 11-19.
75. Rees CJ, Henderson AH, Belafsky PC, (2009). Postviral vagal neuropathy. Ann Otol Rhinol Laryngol 118: 247-252.
76. Ryan NM, Vertigan AE, Bone S, Gibson PG, (2010). Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough 6: 5.
77. Sadofsky LR, Campi B, Trevisani M, Compton SJ, Morice AK, (2008). Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine. Exp Lung Res 34: 681-693.
78. Smith J, Woodcock A, (2008). New developments in the objective assessment of cough. Lung 186 (Suppl. 1): S48-S54.
79. Smith J, Woodcock A, Houghton L, (2010a). New developments in reflux-associated cough. Lung 188 (Suppl. 1): S81-S86.
80. Smith J, Decalmer S, Kelsall A, McGuiness K, Jones H, Galloway S, et al,. (2010b). Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 139: 754-762.
81. Spector SL, Tan RA, (2004). Effectiveness of montelukast in the treatment of cough-variant asthma. Ann Allergy Asthma Immunol 93: 232-236. (Pubitemid 39280525)
82. Tatar M, Plevkova J, Brozmanova M, Pecova R, Kollarik M, (2009). Mechanisms of the cough associated with rhinosinusitis. Pulm Pharmacol Ther 22: 121-126.
83. The Nielsen Company (2007). ACNielsen Strategic Planner:1.
84. Tokayer AZ, (2008). Gastroesophageal reflux disease and chronic cough. Lung 186 (Suppl. 1): S29-S34.